News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • CNTB develops rademikibart to deliver rapid lung-function gains in acute asthma and COPD exacerbations.
  • CNTB market cap ~ $138.5M, shares trade near $2.20 after a $20.2M placement.
  • Company reports about $46M cash on the balance sheet.
  • Upcoming clinical readouts will determine whether rademikibart differentiates from Dupixent.
  • The setup is a binary, high-volatility swing trade; size positions accordingly.
  • Positive readouts could materially re-rate the stock, while negative results would likely cause sharp downside.

Latest Articles

IONOS Shares Jump After Bank of America Starts Coverage with Buy Rating

IONOS Shares Jump After Bank of America Starts Coverage with Buy Rating

IONOS stock climbed sharply after Bank of America Global Research began coverage with a Buy recommendation and a €37 price target. Analysts at BofA highlighted the company’s exposure to expanding European sovereign cloud demand and projected multi-year revenue and adjusted EPS growth that they view as underappreciated by the market. The initiation …

Watches of Switzerland Held Private-sale Talks, Sources Say

Watches of Switzerland Held Private-sale Talks, Sources Say

Watches of Switzerland Group, listed on the London Stock Exchange, has been involved in talks in recent months over possible offers to take the company private, according to three people close to the matter. The stock has climbed this year on robust demand for high-end watches, yet remains well below its 2022 peak. Company executives engaged with i…

Goldman Raises Nio to Buy, Cites Model Momentum and 2026 Profit Turnaround

Goldman Raises Nio to Buy, Cites Model Momentum and 2026 Profit Turnaround

Goldman Sachs has upgraded Nio to Buy from Neutral and increased its 12-month targets to $7 for the ADRs and HK$55 for the Hong Kong-listed shares, implying roughly 47% upside. The bank points to strong demand for the new ES8 and ES9 models, a leading market share in the premium NEV segment, and forecasts for a 2026 swing to adjusted net profit and…

Saudi Stocks Slip; Tadawul All Share Ends Down 0.16%

Saudi Stocks Slip; Tadawul All Share Ends Down 0.16%

Saudi Arabia's equity market closed modestly lower on Monday, with the Tadawul All Share index slipping 0.16%. Losses concentrated in the Industrial Investment, Petrochemicals and Insurance sectors weighed on the session, even as several individual stocks posted significant gains. Oil futures rose sharply while gold futures and the U.S. dollar were…

Intel Commits €5 Billion to Expand Leixlip Campus to Meet AI and HPC Demand

Intel Commits €5 Billion to Expand Leixlip Campus to Meet AI and HPC Demand

Intel has launched a €5 billion ($5.7 billion) capital investment program to upgrade its Leixlip, Ireland campus, increase European production of Intel 3 silicon wafers and support upcoming Intel Xeon processors. The U.S. chipmaker said the work will expand capacity, connect factories on the campus, advance research and development and retrain staf…

Goldman Upgrade Drives Early Gains in NIO After Strong Delivery Momentum

Goldman Upgrade Drives Early Gains in NIO After Strong Delivery Momentum

NIO shares rose in pre-market trading following a Goldman Sachs upgrade from Neutral to Buy and a $7 price target. The broker pointed to NIO's robust deliveries - including a 67% year-over-year rise in volumes in H1 2026 and a 107,658-vehicle Q2 tally - and refreshed financial forecasts that put full-year 2026 revenue and volume growth well above p…

Petco shares slip after CHRO disposes of $508,000 in stock

Petco shares slip after CHRO disposes of $508,000 in stock

Petco Health and Wellness Company Inc. (NASDAQ: WOOF) saw its shares fall 1.6% in premarket trading after disclosure that Chief Human Resources Officer Holly May sold 200,000 Class A shares on July 9 for roughly $508,000. The Form 4 filing details the transaction price range and the executive's remaining holdings, which are largely composed of rest…

Babcock & Wilcox Unveils $50 Million Repurchase Plan; Shares Tick Higher

Babcock & Wilcox Unveils $50 Million Repurchase Plan; Shares Tick Higher

Babcock & Wilcox Enterprises (NYSE:BW) announced a board-approved program to repurchase up to $50 million of its common stock. The company said it expects to begin repurchases after filing its Quarterly Report on Form 10-Q for the second quarter of 2026. Shares rose about 4% on the announcement. The program allows a variety of purchase methods, has…

Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors

Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors

Pliant Therapeutics announced the appointments of Dr. Flavia Borellini and Dr. Robert Iannone to its Board of Directors, bringing extensive global oncology drug development and regulatory expertise. These additions aim to support the advancement of Pliant's clinical-stage integrin-based drug programs, including its lead candidate PLN-101095 targeti…

Braiin Launches Agentic AI Workforce ARIA to Capture the US$32.0 Billion Global Real Estate Software Market by 2033

Braiin Launches Agentic AI Workforce ARIA to Capture the US$32.0 Billion Global Real Estate Software Market by 2033

Braiin Limited announced the release of ARIA, an agentic AI-native workforce platform designed to automate and streamline multi-step workflows across property management, leasing, compliance, accounting support, and customer engagement in the real estate sector. ARIA aims to reduce manual administrative tasks and improve operational efficiency by c…

Mingteng International Announces Full Launch of ERP and MES Systems, Advancing Digitalization in Mold Manufacturing

Mingteng International Announces Full Launch of ERP and MES Systems, Advancing Digitalization in Mold Manufacturing

Mingteng International Corporation Inc., a Nasdaq-listed automotive mold developer in China, announced the complete rollout of its Enterprise Resource Planning (ERP) and Manufacturing Execution System (MES) at its Wuxi subsidiary. This digital transformation shift aims to improve operational efficiency, cost management, and delivery precision, supp…

Guardforce AI to Present Live, Answer Questions, at Skyline Signature Series™ on July 22, 2026, at 11:00 AM ET

Guardforce AI to Present Live, Answer Questions, at Skyline Signature Series™ on July 22, 2026, at 11:00 AM ET

Guardforce AI Co., Limited announced that its management team including CEO Lei Wang will present at the Skyline Signature Series on July 22, 2026, to discuss recent strategic innovations such as their AI for Service Operating System. The live, interactive event aims to connect with investors and provide insights into the company's advancements in …

Aterian Issues Urgent Call to Action: Only 285,000 Votes or 2.7% Separates Stockholders From Securing Value

Aterian Issues Urgent Call to Action: Only 285,000 Votes or 2.7% Separates Stockholders From Securing Value

Aterian, Inc. has postponed its special shareholder meeting to July 17, 2026, urging shareholders to approve the proposed asset sale of its marquee brand portfolios and an accompanying investment transaction. The company warns that failure to approve these proposals could result in common stockholders receiving very little to no value. The asset sa…

Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development

Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development

Cue Biopharma announced the appointment of Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development. Dr. Borie brings over two decades of experience in immunology and clinical development, previously serving in leadership roles at major biotech and pharmaceutical companies. This strategic hire aligns with Cue Biopharm…